Russia is set to begin human clinical trials of a groundbreaking personalized mRNA cancer vaccine by late 2025, targeting melanoma…
Trending
- CAPPA highlights media’s role in reducing NCD
- Chrisland university awards first-class degrees amid growing enrolment
- Women farmers learn smart agriculture techniques in Abuja
- African experts call for urgent action to reduce maternal deaths
- Climate inaction costs lives as adaptation finance lags—UNEP
- NPC strengthens data-driven leadership with new acting chairman
- UNIBEN empowers students with car servicing skills
- WHO warns climate inaction threatens global health
